Press Release: Fifth Annual Summit on Disclosure for Drug, Device & Biotech Companies Features Global HCP Contracting and Data Collection
  • A Hybrid Conference, Internet Event and Training Tool
  • The Leading Forum on Disclosure, Transparency and Aggregate Spend for Drug, Device and Biotech Companies
  • February 19 - 21, 2013
  • Onsite at the Ritz-Carlton in Washington, DC
  • Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
  • www.DisclosureSummit.com
PRESS RELEASE
Phone: 800-503-0112
Email: registration@hcconferences.com
Website: www.DisclosureSummit.com
EARLY BIRD REGISTRATION
- SAVE UP TO $200 -
Register by Friday, January 18, 2013 for Early
Bird $200 discount.
Click here to register.

BROCHURE NOW AVAILABLE
Click here to download brochure.

WASHINGTON DC USA -- MEDICAL DEVICE UPDATE NEWS SERVICE™ -- JANUARY 7, 2013: The Fifth Annual Summit on Disclosure for Drug, Device and Biotech Companies, www.DisclosureSummit.com, will be held February 19 - 21, 2013 at the Ritz-Carlton in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).

FEATURING GLOBAL HCP CONTRACTING AND DATA COLLECTION BY

Andy Bender, MS, MBA
President, Polaris, New York, NY
Ben Carmel, MS
Manager, Polaris, New York, NY

Sujata T. Dayal
Corporate Vice President & Chief Compliance Officer -Global Operations, Biomet, Inc., Warsaw, IN


Elize Hurry, LLB
Business Conduct Specialist II, Gilead Sciences Inc., Foster City, CA



FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

With Special Sessions on Domestic and Global Transparency Initiatives

February 19 - 21, 2013

Onsite:
The Ritz-Carlton
Washington, DC

Online:
Live and Archived for 6 Months

MEDIA PARTNERS

SPONSORED BY
SPECIAL PCF REGISTRATION DISCOUNT
Click here for Special Pharmaceutical Compliance Association Member Registration Discount.

TUITION SCHOLARSHIPS
The Disclosure Summit is now offering partial and full Tuition Scholarships to qualifying representatives of local, state and federal government, consumer advocate organizations, safety net providers, academics, students and health services research organizations.
Click here for more information.

GRANTORS
GOLD


BRONZE

























FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

With Special Sessions on Domestic and Global Transparency Initiatives

A Pharma Congress Conference
February 19 - 21, 2013
ONSITE
The Ritz-Carlton
Washington, DC
OR		 ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
CO CHAIRS

Katrina S. Cahill
Senior Manager, Global Transparency Lead, Biogen Idec, Weston, MA
Rore Middleton, Esq.
Senior Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT
Trudy J. Seeley
Senior Manager, Transparency Operations, Sanofi US, Bridgewater, NJ
PRECONFERENCE: SUNSHINE ACT, DOMESTIC AND GLOBAL AGGREGATE SPEND AND DISCLOSURE 101

Danielle M. Drissel, Esq.
Associate, Hogan Lovells US LLP, Washington, DC
Jack T. Tanselle
Managing Director, Navigant Consulting, Inc., Indianapolis, IN
Ronald L. Wisor, Jr. Esq.
Partner, Hogan Lovells US LLP, Washington, DC
FEATURING ENFORMCEMENT UPDATE BY

Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells US LLP, Former Executive Assistant US Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
David Hart, Esq.
Senior Assistant Attorney General, Oregon Department of Justice, Salem, OR

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former First Assistant US Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC
Marilyn May, Esq.
Deputy Chief for Affirmative Litigation, US Attorney's Office, Eastern District of Pennsylvania, United States Department of Justice, Philadelphia, PA
STATE DISCLOSURE LAW UPDATE

Natasha F. Thoren, JD, LLM
Associate, Pharmaceutical Industry Health, Regulatory Practice Group, Epstein Becker & Green, New York, NY
IMPLICATIONS FOR PHARMA AND PHYSICIANS

Jeremy A. Lazarus, MD
Board-certified Psychiatrist, President, American Medical Association, Denver, CO
David J. Rothman, PhD
Director, Center for the Study of Society and Medicine, Bernard Schoenberg Professor of Social Medicine, College of Physicians and Surgeons, Columbia University, President, Institute on Medicine as a Profession, New York, NY

THE CONTINUING ROLE
OF CONGRESS

Jack Mitchell
Chief of Oversight and Investigations, Special Committee on Aging, United Sates Senate, Former Director, Commissioner's Office of Special Investigations, Food and Drug Administration, Washington, DC

DEALING WITH
THE CONSEQUENCES

Seth H. Lundy, Esq.
Partner and Deputy Chair, FDA and Life Sciences Practice Group, King & Spalding, Washington, DC

FRAUD AND
ABUSE RISKS

Meenakshi Datta, Esq.
Partner, Sidley Austin LLP, Chicago, IL

GLOBAL TRANSPARENCY UPDATE

Ronny Arijs
Vice President Global Sustainability and Chief Compliance Officer, Grunenthal, Member, EFPIA Compliance Workgroup, Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium
Evelyne Lemaire
Director, Global Pharmaceutical and LIfe Sciences, PwC LLP, Zurich, Switzerland
Jason Staples, Esq.
Senior Counsel, International Legal Operations, Abbott Laboratories, Chicago, IL

David Wysocky
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers, Florham Park, NJ
Kevin Yamaga-Karns, Esq.
Senior Director, Legal and Compliance, Eli Lilly Japan, Hyogo, Japan
NEW DEVELOPMENTS IN DISCLOSURE, ANTICORRUPTION AND FCPA ENFORCEMENT

Michael D. Bell, Esq.
President, R-Squared, Princeton, NJ
Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC
DRUG SAMPLE DISCLOSURE

Kendra Martello, Esq.
Assistant General Counsel, PhRMA, Washington, DC
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Pharmaceutical Services, LLC; Principal, Porzio, Bromberg & Newman PC, Morristown, NJ
R&D AND CLINICAL TRIALS

Diane Bieri, Esq.
Partner, Arnold & Porter LLP, Former Executive Vice President and General Counsel, PhRMA, Washington, DC
Seth Whitelaw, JD, LLM, SJD
Director, Life Sciences Regulatory Compliance Practice, Deloitte & Touche LLP, Former R&D Compliance Officer, GlaxoSmithKline, Former Legal Compliance Officer, SmithKline Beecham Pharmaceuticals, Philadelphia, PA
Kim Zahan, MBA
Director R&D Financial Compliance, GlaxoSmithKline, King of Prussia, PA
AGG SPEND 201 - 301: BEYOND THE BASICS

Marc Adler, Esq.
Principal, R-Squared, Princeton, NJ
Michael D. Bell, Esq.
President, R-Squared, Princeton, NJ
ADVANCED IMPLEMENTATION ISSUES

Mark Linver
Managing Director, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, New York, NY
Suj Patel
Director, Life Sciences Practice, Huron Consulting Group, New York, NY
GLOBAL HCP CONTRACTING AND DATA COLLECTION

Andy Bender, MS, MBA
President, Polaris, New York, NY
Ben Carmel, MS
Manager, Polaris, New York, NY

Sujata T. Dayal
Corporate Vice President & Chief Compliance Officer -Global Operations, Biomet, Inc., Warsaw, IN


Elize Hurry, LLB
Business Conduct Specialist II, Gilead Sciences Inc., Foster City, CA
FAIR MARKET VALUE

Mark A. DeWyngaert, MBA, PhD
Managing Director, Huron Consulting Group, New York, NY
Jen Johnson, CFA
Partner, VMG Health, Dallas, TX
AGGREGATE SPEND FOR SMALL AND MID-SIZED COMPANIES

Danielle Bacco
Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT
John B. Knighton, Esq. (Invited)
Director and Interim Chief Compliance Officer, Wright Medical Technology, Inc., Arlington, TN
Wendy Tsuei, MBA
Associate Director, Aggregate Spend, Corporate Ethics and Compliance, Eisai Co., Ltd., Woodcliff Lake, NJ

ATTENDANCE OPTIONS
TRADITIONAL CONFERENCE ATTENDANCE
By attending onsite, you will be able to more completely immerse in the subject matter, get professional networking opportunities, and interact with the faculty. Register for Preconference and/or Conference.
LIVE AND ARCHIVED INTERNET ATTENDANCE
Watch the conference plenary session in live streaming video and listen to streaming audio of track sessions over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office

INTERNET INTERFACE SAMPLE

Click here for a sample stream





SAVE THE DATES

FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND
A Hybrid Conference and Internet Event
February 19 - 21, 2013
The Ritz-Carlton
Washington, DC
www.DisclosureSummit.com
SEVENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals
Cosponsored by Pharmaceutical Compliance Forum
May 21 - 23, 2013
Meliá Castilla Hotel
Madrid, Spain
www.InternationalPharmaCongress.com
THIRD ASIA PACIFIC PHARMACEUTICAL
COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by Pharmaceutical Compliance Forum
Media Partners: Life Science Compliance and RX Compliance Report
September 10 - 12, 2013
Kuala Lampur, Malaysia
www.AsianPharmaCongress.com
FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
October 28 - 30, 2013
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com

SUMMIT REGISTRATION

For Summit registration information, visit www.DisclosureSummit.com/registration.php, email registration@hcconferences.com, or call 800-503-0112.


SUMMIT EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information, visit www.DisclosureSummit.com/promotional/index.html, or contact Justin Sorensen, Exhibit Manager, at (206) 452-0609 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.